Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 12-month results
H Yokoi, T Ohki, K Kichikawa, M Nakamura… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: This multicenter, prospective, post-market surveillance study in Japan evaluates
the paclitaxel-coated Zilver PTX stent in real-world patients with complex lesions …
the paclitaxel-coated Zilver PTX stent in real-world patients with complex lesions …
[HTML][HTML] First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease
J Lammer, M Bosiers, T Zeller, M Schillinger… - Journal of vascular …, 2011 - Elsevier
BACKGROUND: A novel self-expanding drug-eluting stent was designed to slowly release
everolimus to prevent restenosis following peripheral arterial intervention. The purpose of …
everolimus to prevent restenosis following peripheral arterial intervention. The purpose of …
[HTML][HTML] Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries
A Mohapatra, Z Saadeddin, DJ Bertges… - Journal of vascular …, 2020 - Elsevier
Objective Drug-coated balloons (DCB) and drug-eluting stents (DES) have significantly
altered treatment paradigms for femoropopliteal lesions. We aimed to describe changes in …
altered treatment paradigms for femoropopliteal lesions. We aimed to describe changes in …
Long-term results from the MAJESTIC trial of the Eluvia paclitaxel-eluting stent for femoropopliteal treatment: 3-year follow-up
S Müller-Hülsbeck, K Keirse, T Zeller, H Schroë… - CardioVascular and …, 2017 - Springer
Purpose To report the 3-year results of the MAJESTIC first-in-human study of the Eluvia Drug-
Eluting Vascular Stent System for treating femoropopliteal artery lesions. Methods The …
Eluting Vascular Stent System for treating femoropopliteal artery lesions. Methods The …
Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative
DJ Bertges, A Sedrakyan, T Sun… - Circulation …, 2020 - Am Heart Assoc
Background: To compare mortality after treatment of superficial femoral-popliteal artery
disease with paclitaxel and nonpaclitaxel devices using a multicenter vascular registry …
disease with paclitaxel and nonpaclitaxel devices using a multicenter vascular registry …
COMPARE: prospective, randomized, non-inferiority trial of high-vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
S Steiner, A Schmidt, T Zeller, G Tepe… - European Heart …, 2020 - academic.oup.com
Abstract Aims Drug-coated balloons (DCBs) for femoropopliteal interventions have not been
tested against each other. We aimed to directly compare efficacy and safety of a high-dose …
tested against each other. We aimed to directly compare efficacy and safety of a high-dose …